SCHD vs XVV
Schwab US Dividend Equity ETF vs iShares ESG Select Screened S&P 500 ETF
Which is better, SCHD or XVV?
Large Cap Value against Large Cap Blend.
SCHD has a lower expense ratio. SCHD led over 1Y, XVV over 3Y, 5Y and the full window. SCHD is less concentrated, with 41.8% of the fund in its ten largest positions against 42.2%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | SCHD | XVV |
|---|---|---|
| Expense Ratio | 0.06%Best | 0.08% |
| AUM | $112.1B | $677M |
| Dividend Yield | 3.00% | 0.90% |
| Holdings | 103 | 448 |
| YTD Return | +23.68%Best | +12.43% |
| 1Y Return | +28.36%Best | +14.81% |
| 3Y Return (annualized) | +16.20% | +22.84%Best |
| 5Y Return (annualized) | +10.07% | +13.04%Best |
| Volatility (annualized) | 15.2%Best | 16.0% |
| Max Drawdown | -16.9%Best | -27.2% |
| $10,000 over 5 years | $16,156 | $18,457Best |
| Top 10 Weight | 41.8%Best | 42.2% |
| Fund Family | Charles Schwab Asset Management | iShares by BlackRock (US) |
| Category | Equity | Equity |
| Style | Large Cap Value | Large Cap Blend |
| Inception | Oct 20, 2011 | Sep 22, 2020 |
Volatility and max drawdown are measured over the window both funds cover: Sep 24, 2020 to Sep 22, 2026 (6 years).
SCHD vs XVV growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 6 years both funds cover.
SCHD vs XVV Performance
Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management and iShares ESG Select Screened S&P 500 ETF (XVV) is an ETF from iShares by BlackRock (US). Over the past year SCHD returned +28.36% while XVV returned +14.81%. Year to date, SCHD is up 23.68% versus a gain of 12.43% for XVV.
Over three years, SCHD compounded at +16.20% per year against +22.84% for XVV; over five years the annualized figures are +10.07% and +13.04% respectively. Across the full 6-year window we track, XVV has the edge at +16.78% annualized vs +14.78%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
XVV has been the more volatile fund, with annualized monthly volatility of 16.0% compared with 15.2% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -16.9% for SCHD and -27.2% for XVV. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.69. They move together some of the time, and apart the rest.
Fees and Cost Over Time
SCHD charges 0.06% per year while XVV charges 0.08%. On a $10,000 position that is $6 vs $8 annually, a gap of $2 per year that compounds over a long holding period. On income, SCHD currently yields 3.00% against 0.90% for XVV.
Holdings Overlap
77.7% of SCHD's money is in holdings XVV also owns. 7.4% of XVV's money is in holdings SCHD also owns.
Most of SCHD is already inside XVV. Owning both mostly buys the same companies twice.
39 positions in common, counted across the 100 positions we hold weights for in SCHD and 435 in XVV, against full books of 103 and 448.
What only one of them owns
Our book lists 392 positions for XVV that do not appear in our book for SCHD (91.9% of the fund), and 60 for SCHD that do not appear in XVV (22.2%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in SCHD | Weight in XVV | Difference |
|---|---|---|---|
| MRKMerck & Company Inc | 4.77% | 0.61% | 4.16% |
| AMGNAmgen Inc. | 4.70% | 0.39% | 4.31% |
| ABTAbbott Laboratories | 4.69% | 0.32% | 4.37% |
| KOCoca Cola Co. | 4.17% | 0.58% | 3.59% |
| HDHome Depot Inc/The | 3.88% | 0.55% | 3.33% |
| UNHUnitedhealth Group Incorporated | 3.82% | 0.60% | 3.22% |
| PGProcter & Gamble Company | 3.83% | 0.57% | 3.26% |
| VZVerizon Communic | 3.97% | 0.35% | 3.62% |
| PEPPepsico Inc. | 3.64% | 0.32% | 3.32% |
| BMYBristol-Myers Squibb Co. | 3.33% | 0.23% | 3.10% |
77.7% of SCHD is already inside XVV.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, SCHD or XVV?
SCHD has an expense ratio of 0.06% while XVV charges 0.08%. SCHD is the cheaper option, by $2 a year on a $10,000 investment.
Which performed better, SCHD or XVV?
Over the past year SCHD returned +28.36% vs +14.81% for XVV, so SCHD leads on 1-year performance. Over the longest common window we track (6 years), SCHD annualized +14.78% vs +16.78% for XVV. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, SCHD or XVV?
XVV has been the more volatile fund at 16.0% annualized versus 15.2% for SCHD. Worst drawdown: SCHD -16.9% vs XVV -27.2%.
Should I hold both SCHD and XVV?
SCHD and XVV have a monthly-return correlation of 0.69, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between SCHD and XVV?
77.7% of SCHD's money is in holdings XVV also owns. 7.4% of XVV's is in holdings SCHD also owns. They hold 39 positions in common, counted across the 100 positions we hold weights for in SCHD and 435 in XVV.
Which pays a higher dividend, SCHD or XVV?
SCHD yields 3.00% while XVV yields 0.90%, so SCHD currently pays the higher dividend yield.
Is XVV better than SCHD?
SCHD has a lower expense ratio. SCHD led over 1Y, XVV over 3Y, 5Y and the full window. SCHD is less concentrated, with 41.8% of the fund in its ten largest positions against 42.2%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.